Lv3
280 积分 2026-03-10 加入
Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer
2个月前
已完结
Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance
2个月前
已完结
Comparative Toxicovigilance of Capmatinib and Tepotinib in NSCLC: Respiratory Signal Detection and Adverse Event Profiling via FAERS
2个月前
已完结
Tyrosine kinase inhibitors for gastrointestinal stromal tumor
2个月前
已完结